Introduction
Nigeria is the most populous country in Africa, with over 160 million people. The high population growth rate, coupled with poor living conditions, is a potential factor for widespread infection; highly virulent antibiotic-resistant Staphylococcus aureus, such as methicillin-resistant strains (MRSA), is a major concern in such a densely populated community. Information on drug-resistant strains of S. aureus in Nigeria is limited but indicates that this harmful bacterium, including antibiotic-susceptible strains, exists in hospital settings. This made it necessary to determine the molecular profile of S. aureus isolates from Nigeria.
Methods
A total of 73 biological samples (40 throat, 23 nasal, and 10 wound swabs) were collected from patients and healthcare workers in five health institutions in Lagos and Owerri, Nigeria. The samples were promptly analyzed for S. aureus by standard microbiological techniques at the Nigerian Institute of Medical Research, Lagos. Positive isolates were subjected to genetic and antimicrobial susceptibility assessment at the Center for Emerging Infectious Diseases, University of Iowa, USA.
Results
Of the 73 samples, S. aureus was isolated from 38 (52%); 9 (24%) of the isolates carried the Panton Valentin leukocidin gene (PVL) while 15 (42%) of the isolates possessed methicillinresistance genes (mecA). Antibiotic susceptibility testing showed that thirty-two isolates (84%) were resistant to tetracycline, 29 (76%) resistant to TMP/SMX, 16 (42%) to oxacillin, 7 (18%) to levofloxacin, 5 (13%) to erythromycin, and 5 (13%) to gentamycin. Notable spa types included t064 (11/38, 29%), 8 of which were positive for mecA gene, and t355 (10/38, 26%), of which 5 were positive for PVL.
Conclusion
Based on the results, it could be concluded that virulent and antibiotic-resistant S. aureus is a problem in clinical settings in Nigeria. This tends to alert the need for judicious antimicrobial prescribing and proper enlightenment of the population on the dangers of antimicrobial abuse in self-medication.
